We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

40 hedge funds and large institutions have $42.1M invested in Genocea Biosciences, Inc. in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

748% more call options, than puts

Call options by funds: $712K | Put options by funds: $84K

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

8% more capital invested

Capital invested by funds: $38.9M → $42.1M (+$3.16M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 41 → 40 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
40
Holders Change
-1
Holders Change %
-2.44%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
11
Reduced
7
Closed
4
Calls
$712K
Puts
$84K
Net Calls
+$628K
Net Calls Change
+$403K

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$92.4K
2
Citadel Advisors
Citadel Advisors
Florida
+$51.9K
3
BC
BIT Capital
Germany
+$38.1K
4
Millennium Management
Millennium Management
New York
+$20.2K
5
Jane Street
Jane Street
New York
+$20.1K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$83.4K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$25K
3
Simplex Trading
Simplex Trading
Illinois
-$24K
4
VF
Virtu Financial
New York
-$15K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$13.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$13M – – –
ACA
2
Avoro Capital Advisors
New York
$6.36M – – –
BI
3
BVF Inc
California
$5.02M – – –
CC
4
Commodore Capital
New York
$3.85M – – –
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$3.22M -$83.4K -76,589 -3%
KCM
6
Kingdon Capital Management
New York
$2.46M – – –
Citadel Advisors
7
Citadel Advisors
Florida
$2.3M +$51.9K +47,617 +3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.97M +$109 +100 +0%
BC
9
Boxer Capital
California
$1.42M – – –
AICPI
10
ABG Innovation Capital Partners III
Hong Kong
$469K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$364K +$92.4K +84,853 +41%
Millennium Management
12
Millennium Management
New York
$269K +$20.2K +18,569 +9%
HighTower Advisors
13
HighTower Advisors
Illinois
$266K – – –
IC
14
Ikarian Capital
Texas
$259K +$10.4K +9,515 +5%
BlackRock
15
BlackRock
New York
$225K -$5.53K -5,076 -3%
Northern Trust
16
Northern Trust
Illinois
$89K – – –
Bank of America
17
Bank of America
North Carolina
$72K -$29 -27 -0%
Group One Trading
18
Group One Trading
Illinois
$63K +$7.08K +6,503 +15%
Renaissance Technologies
19
Renaissance Technologies
New York
$53K +$16.6K +15,200 +55%
Commonwealth Equity Services
20
Commonwealth Equity Services
Massachusetts
$50K +$8.81K +8,088 +25%
BC
21
BIT Capital
Germany
$43.8K +$38.1K +35,000 New
Morgan Stanley
22
Morgan Stanley
New York
$35K +$15.8K +14,527 +107%
State Street
23
State Street
Massachusetts
$30K +$5.12K +4,700 +24%
BFM
24
Boothbay Fund Management
New York
$25K – – –
Jane Street
25
Jane Street
New York
$23K +$20.1K +18,433 New
1
2

GNCA Hedge Fund Activity: Q1 2022 in Review

40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2022, worth a combined $42.1M — up 8.1% from $38.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of GNCA and 3 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 11 added.

The largest buyer was Geode Capital Management, adding an estimated $92.4K. The largest seller was Point72 Asset Management, cutting an estimated $83.4K.

  • 40 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2022, down from 41 in Q4 2021.
  • Funds reported $42.1M of Genocea Biosciences, Inc. stock for Q1 2022, up 8.1% quarter-over-quarter.
  • 3 funds opened new Genocea Biosciences, Inc. positions in Q1 2022 and 4 closed out, a net change of -1 holder.
  • The largest Genocea Biosciences, Inc. buyer in Q1 2022 was Geode Capital Management, an estimated $92.4K added.
  • The largest Genocea Biosciences, Inc. seller in Q1 2022 was Point72 Asset Management, an estimated $83.4K sold.

Based on aggregated 13F filings for Q1 2022.